Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites

Graphical abstract

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2017-07, Vol.67 (1), p.40-46
Hauptverfasser:	Sinha, Rohit, Lockman, Khalida A, Mallawaarachchi, Nethmee, Robertson, Marcus, Plevris, John N, Hayes, Peter C
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Adrenergic beta-Antagonists - therapeutic use Aged Ascites Ascites - drug therapy Ascites - mortality Beta blockers Bleeding Carbazoles - therapeutic use Carvedilol Cause of Death Cirrhosis Decompensated liver disease Drug therapy Female Gastroenterology and Hepatology Humans Liver cirrhosis Liver Cirrhosis - drug therapy Liver Cirrhosis - mortality Liver diseases Male Middle Aged Mortality Non-selective beta-blockers Patients Peritonitis Propanolamines - therapeutic use Prophylaxis Retrospective Studies Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!